Ling Mei

6.8k total citations
116 papers, 3.8k citations indexed

About

Ling Mei is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Ling Mei has authored 116 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Biomedical Engineering, 36 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Ling Mei's work include Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (20 papers) and RNA Interference and Gene Delivery (15 papers). Ling Mei is often cited by papers focused on Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (20 papers) and RNA Interference and Gene Delivery (15 papers). Ling Mei collaborates with scholars based in China, United States and South Korea. Ling Mei's co-authors include Zhirong Zhang, Qin He, Huile Gao, Stephan R. Targan, Jerome I. Rotter, Qianyu Zhang, Kent D. Taylor, Yayuan Liu, Hsiu‐O Ho and Te‐Hua Fang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Gastroenterology.

In The Last Decade

Ling Mei

110 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Mei China 39 1.3k 897 895 717 664 116 3.8k
Hu‐Lin Jiang China 46 3.0k 2.2× 1.8k 2.0× 2.2k 2.4× 755 1.1× 538 0.8× 195 6.7k
Robbert J. Kok Netherlands 44 3.0k 2.2× 1.7k 1.9× 1.2k 1.3× 382 0.5× 614 0.9× 136 6.4k
Wenyi Gu Australia 41 1.9k 1.4× 806 0.9× 1.2k 1.3× 230 0.3× 775 1.2× 155 5.8k
Yuhong Xu China 33 1.7k 1.2× 1.0k 1.1× 1.1k 1.2× 215 0.3× 382 0.6× 154 3.8k
Xiaozhou Mou China 38 1.9k 1.5× 974 1.1× 2.5k 2.7× 240 0.3× 535 0.8× 185 5.8k
Todd D. Giorgio United States 30 1.6k 1.2× 764 0.9× 868 1.0× 384 0.5× 484 0.7× 93 3.4k
Masayuki Yokoyama Japan 42 1.4k 1.1× 2.5k 2.8× 1.1k 1.2× 169 0.2× 603 0.9× 141 5.5k
Zongmin Zhao United States 33 1.7k 1.3× 1.2k 1.3× 1.5k 1.7× 189 0.3× 732 1.1× 71 4.3k
Kenneth A. Howard Denmark 42 4.3k 3.2× 1.6k 1.7× 1.5k 1.7× 578 0.8× 520 0.8× 108 6.8k
Timothy M. Fan United States 37 1.6k 1.2× 979 1.1× 1.1k 1.2× 457 0.6× 391 0.6× 170 4.7k

Countries citing papers authored by Ling Mei

Since Specialization
Citations

This map shows the geographic impact of Ling Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Mei more than expected).

Fields of papers citing papers by Ling Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Mei. The network helps show where Ling Mei may publish in the future.

Co-authorship network of co-authors of Ling Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Mei. A scholar is included among the top collaborators of Ling Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Mei. Ling Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Ling, Zhuang Hu, Jierui Yan, et al.. (2025). Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined. Aggregate. 6(11). 1 indexed citations
2.
Ding, Qihang, Chengyong Shi, Hao Wu, et al.. (2025). Selenium-derived bioactive enablers for advanced therapies: From molecular redox modulation to broad-spectrum disease applications. Bioactive Materials. 57. 182–230.
3.
Ding, Qihang, Lin Chen, Chunbin Li, et al.. (2025). From Light to Cure: Precision Phototherapies for Antibiotic‐Refractory Biofilm Infections. Angewandte Chemie International Edition. 64(43). e202510900–e202510900.
4.
Ding, Qihang, Yifan Zhang, Xiaotang Fan, et al.. (2025). Engineering small-molecule phototheranostics for infectious disease imaging and therapy in NIR-II. TrAC Trends in Analytical Chemistry. 192. 118394–118394. 1 indexed citations
5.
Ding, Qihang, et al.. (2025). Beyond Enzyme Mimics: Engineering Photo‐Responsive Nanozymes for Therapeutic Innovation. Advanced Materials. 38(3). e10661–e10661.
6.
Ding, Qihang, Siqi Huang, Zihan Zhang, et al.. (2025). Integration of Photodiagnosis and Therapy Guided by Micro/Nanorobots. Advanced Materials. 37(18). e2420359–e2420359. 17 indexed citations
7.
He, Sanwei, et al.. (2024). The impact of high-speed rail network on high-end service industry development: Evidence from the Yangtze River Delta, China. Research in Transportation Business & Management. 58. 101253–101253. 4 indexed citations
8.
He, Ruo, Hang Xu, Ling Mei, et al.. (2024). Synthesis of Hydrogen Peroxide in Neutral Media by an Iron-Doped Nickel Phosphide Catalyst. Inorganic Chemistry. 63(50). 23818–23828. 1 indexed citations
9.
Liao, Li, et al.. (2024). Total synthesis and antibacterial evaluation of lupalbigenin and isolupalbigenin. Journal of Asian Natural Products Research. 27(4). 556–567. 2 indexed citations
10.
Dubey, Nileshkumar, Juliana Silva Ribeiro, Zhaocheng Zhang, et al.. (2023). Gelatin methacryloyl hydrogel as an injectable scaffold with multi-therapeutic effects to promote antimicrobial disinfection and angiogenesis for regenerative endodontics. Journal of Materials Chemistry B. 11(17). 3823–3835. 20 indexed citations
11.
Mei, Ling, Tao Wang, Yueyue Chen, et al.. (2022). Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection. Journal of Translational Medicine. 20(1). 12–12. 27 indexed citations
12.
Mei, Ling, Minzhi Yu, Yayuan Liu, et al.. (2022). Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration. Nanomedicine Nanotechnology Biology and Medicine. 44. 102571–102571. 15 indexed citations
13.
He, Hongliang, et al.. (2022). Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy. Journal of Controlled Release. 348. 1016–1027. 21 indexed citations
14.
Tang, Jiajing, Qiantao Wang, Qianwen Yu, et al.. (2018). A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery. Acta Biomaterialia. 83. 379–389. 61 indexed citations
16.
Tang, Xian, Jingdong Rao, Sheng Yin, et al.. (2018). PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment. European Journal of Pharmaceutical Sciences. 127. 161–174. 26 indexed citations
17.
Liu, Yayuan, Ling Mei, Qianwen Yu, et al.. (2015). Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides. Amino Acids. 47(12). 2533–2539. 17 indexed citations
18.
Mei, Ling, Ling Fu, Kairong Shi, et al.. (2014). Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG. International Journal of Pharmaceutics. 468(1-2). 26–38. 90 indexed citations
19.
Mei, Ling, et al.. (2007). A new fluorescent probe of rhodamine B derivative for the detection of copper ion. Talanta. 72(5). 1717–1722. 95 indexed citations
20.
Schluender, Stefanie J., Andrew Ippoliti, Marla C. Dubinsky, et al.. (2007). Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis?. Diseases of the Colon & Rectum. 50(11). 1747–1753. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026